Promising trial data published for new menopause drug

Posted on 2008-09-29 07:54:09 in Estrogen | Women's Health |

Pharmaceutical company Wyeth has released the results of a study of its new tissue selective estrogen complex (TECS), menopause drug Aprela, a combination of conjugated estrogens and bazedoxifine, an experimental selective estrogen receptor modulator (SERM), designed to prevent and treat postmenopausal osteoporosis.

Results of the study of 3,400 women showed that the drug reduced hot flashes and improved sleep problems, but did not increase breast tenderness. The fact that the drug does not increase breast tenderness is important because increased breast tenderness is one of the main reasons why women choose to stop taking hormone replacement therapy (HRT).

Other studies on Aprela have shown that the drug improves bone mineral density, and, at high doses, reduces excess growth of the endometrium, which can cause breakthrough bleeding and may cause cancer.

News release: Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene / Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms. Wyeth website. September 25th 2008.

 


Health Headlines

Postmenopausal women who consume diets in fat are at increased risk of ischemic stroke.
Oregon State University (USA) scientists make key discoveries relating to circadian rhythms and their role in healthspan and lifespan.
Study finds that genuine smilers live longer.
Soluble fiber, such as pectin found in apples, may confer anti-inflammatory effects and strengthen the immune system.
Chinese study reveals that frequent napping is associated with an elevated prevalence of type-2 diabetes and impaired fasting glucose.
Five hours or less of sleep a night corresponds to large increases in visceral fat.
Rush University (US) researchers find that older men and women who maintain a purpose in life are less likely to develop Alzheimer’s Disease.
Obese children as young as three years old may have elevated levels of C-Reactive Protein and other inflammatory markers linked to heart disease in adulthood.
Healthy middle-aged men and women with higher blood levels of DHA, a type of omega-3 fatty acid, perform better on tests of reasoning, memory, and vocabulary.
University of California researchers project that the nation’s oldest men and women will experience an 18% annual dementia incidence that increases with age.
Get our Anti-Aging Weekly Newsletter! Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Orlando
workshop
workshops
fellowships
fellowships
symposiums
workshops
International Events
See all events »